{"id":"https://openalex.org/W4415680907","doi":"https://doi.org/10.1016/j.xphs.2025.104046","title":"Demonstration of in vitro-in vivo relationship (IVIVR) and virtual bioequivalence (VBE) between progesterone intravaginal rings using physiologically based pharmacokinetic (PBPK) modelling","display_name":"Demonstration of in vitro-in vivo relationship (IVIVR) and virtual bioequivalence (VBE) between progesterone intravaginal rings using physiologically based pharmacokinetic (PBPK) modelling","publication_year":2025,"publication_date":"2025-10-30","ids":{"openalex":"https://openalex.org/W4415680907","doi":"https://doi.org/10.1016/j.xphs.2025.104046","pmid":"https://pubmed.ncbi.nlm.nih.gov/41173270"},"language":"en","primary_location":{"id":"doi:10.1016/j.xphs.2025.104046","doi":"https://doi.org/10.1016/j.xphs.2025.104046","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.xphs.2025.104046","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://ruj.uj.edu.pl/handle/item/565099","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077089491","display_name":"Kanika Thakur","orcid":"https://orcid.org/0009-0005-3550-5126","observed_orcids":["https://orcid.org/0009-0005-3550-5126"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kanika Thakur","raw_affiliation_strings":["Certara UK Limited, Predictive Technologies Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK. Electronic address: kanika.thakur@certara.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Certara UK Limited, Predictive Technologies Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK. Electronic address: kanika.thakur@certara.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007072703","display_name":"Ola Sternebring","orcid":"https://orcid.org/0000-0002-8204-3623","observed_orcids":["https://orcid.org/0000-0002-8204-3623"]},"institutions":[{"id":"https://openalex.org/I4210128638","display_name":"Ferring Pharmaceuticals (Denmark)","ror":"https://ror.org/03m7mhz19","country_code":"DK","type":"company","lineage":["https://openalex.org/I22138158","https://openalex.org/I4210128638"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Ola Sternebring","raw_affiliation_strings":["Ferring Pharmaceuticals A/S, Global Research & Medical, Kastrup, Denmark"],"raw_orcid":"https://orcid.org/0000-0002-8204-3623","affiliations":[{"raw_affiliation_string":"Ferring Pharmaceuticals A/S, Global Research & Medical, Kastrup, Denmark","institution_ids":["https://openalex.org/I4210128638"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yu-E Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121594","display_name":"Ferring Pharmaceuticals (United States)","ror":"https://ror.org/02ytn5d60","country_code":"US","type":"company","lineage":["https://openalex.org/I22138158","https://openalex.org/I4210121594"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu-E Zhang","raw_affiliation_strings":["Ferring Pharmaceuticals Inc., Parsippany, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ferring Pharmaceuticals Inc., Parsippany, New Jersey, USA","institution_ids":["https://openalex.org/I4210121594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120182000","display_name":"Kevin Wyckoff","orcid":"https://orcid.org/0009-0007-7405-6487","observed_orcids":["https://orcid.org/0009-0007-7405-6487"]},"institutions":[{"id":"https://openalex.org/I4210121594","display_name":"Ferring Pharmaceuticals (United States)","ror":"https://ror.org/02ytn5d60","country_code":"US","type":"company","lineage":["https://openalex.org/I22138158","https://openalex.org/I4210121594"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Wyckoff","raw_affiliation_strings":["Ferring Pharmaceuticals Inc., Parsippany, New Jersey, USA"],"raw_orcid":"https://orcid.org/0009-0007-7405-6487","affiliations":[{"raw_affiliation_string":"Ferring Pharmaceuticals Inc., Parsippany, New Jersey, USA","institution_ids":["https://openalex.org/I4210121594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007613028","display_name":"Iain I. MacDonald","orcid":"https://orcid.org/0000-0001-5937-9973","observed_orcids":["https://orcid.org/0000-0001-5937-9973"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iain Macdonald","raw_affiliation_strings":["Ferring Controlled Therapeutics Limited, Glasgow, UK"],"raw_orcid":"https://orcid.org/0000-0001-5937-9973","affiliations":[{"raw_affiliation_string":"Ferring Controlled Therapeutics Limited, Glasgow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079106999","display_name":"Philippe Pinton","orcid":"https://orcid.org/0000-0002-4227-7687","observed_orcids":["https://orcid.org/0000-0002-4227-7687"]},"institutions":[{"id":"https://openalex.org/I4210128638","display_name":"Ferring Pharmaceuticals (Denmark)","ror":"https://ror.org/03m7mhz19","country_code":"DK","type":"company","lineage":["https://openalex.org/I22138158","https://openalex.org/I4210128638"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Philippe Pinton","raw_affiliation_strings":["Ferring Pharmaceuticals A/S, Global Research & Medical, Kastrup, Denmark"],"raw_orcid":"https://orcid.org/0000-0002-4227-7687","affiliations":[{"raw_affiliation_string":"Ferring Pharmaceuticals A/S, Global Research & Medical, Kastrup, Denmark","institution_ids":["https://openalex.org/I4210128638"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Daniel Paterson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Paterson","raw_affiliation_strings":["Certara UK Limited, Predictive Technologies Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Certara UK Limited, Predictive Technologies Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037195784","display_name":"Krishna Chaitanya Telaprolu","orcid":"https://orcid.org/0000-0002-3439-7152","observed_orcids":["https://orcid.org/0000-0002-3439-7152"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Krishna Chaitanya Telaprolu","raw_affiliation_strings":["Certara UK Limited, Predictive Technologies Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Certara UK Limited, Predictive Technologies Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054966624","display_name":"Sebastian Polak","orcid":"https://orcid.org/0000-0001-8614-0642","observed_orcids":["https://orcid.org/0000-0001-8614-0642"]},"institutions":[{"id":"https://openalex.org/I126596746","display_name":"Jagiellonian University","ror":"https://ror.org/03bqmcz70","country_code":"PL","type":"education","lineage":["https://openalex.org/I126596746"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Sebastian Polak","raw_affiliation_strings":["Certara UK Limited, Predictive Technologies Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK; Chair of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medinan 9, 30-688, Krakow, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Certara UK Limited, Predictive Technologies Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK; Chair of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medinan 9, 30-688, Krakow, Poland","institution_ids":["https://openalex.org/I126596746"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5077089491"],"corresponding_institution_ids":[],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":0.7506,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.62386707,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":96},"biblio":{"volume":"115","issue":"1","first_page":"104046","last_page":"104046"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.6284000277519226,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.6284000277519226,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.17249999940395355,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.07959999889135361,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/progesterone","display_name":"progesterone","score":0.9110000133514404},{"id":"https://openalex.org/keywords/vaginal-ring","display_name":"vaginal ring","score":0.7960000038146973},{"id":"https://openalex.org/keywords/vaginal-gel","display_name":"vaginal gel","score":0.6610000133514404},{"id":"https://openalex.org/keywords/virtual-bioequivalence","display_name":"virtual bioequivalence","score":0.9940000176429749},{"id":"https://openalex.org/keywords/physiologically-based-pharmacokinetic-modelling","display_name":"physiologically based pharmacokinetic modelling","score":0.9819999933242798},{"id":"https://openalex.org/keywords/vaginal-absorption","display_name":"vaginal absorption","score":0.6549999713897705},{"id":"https://openalex.org/keywords/simcyp","display_name":"SimCYP","score":0.8669999837875366},{"id":"https://openalex.org/keywords/in-vitro-release-profile","display_name":"in vitro release profile","score":0.7390000224113464},{"id":"https://openalex.org/keywords/post-approval-changes","display_name":"post-approval changes","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.9258999824523926},{"id":"https://openalex.org/C185867374","wikidata":"https://www.wikidata.org/wiki/Q2562769","display_name":"Physiologically based pharmacokinetic modelling","level":3,"score":0.7569000124931335},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7350000143051147},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7171000242233276},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6682000160217285},{"id":"https://openalex.org/C125287762","wikidata":"https://www.wikidata.org/wiki/Q1758948","display_name":"Absorption (acoustics)","level":2,"score":0.5583999752998352},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.462799996137619},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.45399999618530273},{"id":"https://openalex.org/C2778723060","wikidata":"https://www.wikidata.org/wiki/Q6058566","display_name":"Intravaginal administration","level":3,"score":0.44510000944137573},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41990000009536743},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.4185999929904938},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.37700000405311584},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3614000082015991},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.34709998965263367},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.3319999873638153},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.313400000333786},{"id":"https://openalex.org/C33618052","wikidata":"https://www.wikidata.org/wiki/Q6013136","display_name":"In vitro toxicology","level":3,"score":0.30559998750686646},{"id":"https://openalex.org/C14029885","wikidata":"https://www.wikidata.org/wiki/Q5282807","display_name":"Dissolution testing","level":4,"score":0.2987000048160553},{"id":"https://openalex.org/C2987276129","wikidata":"https://www.wikidata.org/wiki/Q12140","display_name":"Drug administration","level":2,"score":0.2838999927043915},{"id":"https://openalex.org/C2776093070","wikidata":"https://www.wikidata.org/wiki/Q621636","display_name":"Route of administration","level":2,"score":0.26759999990463257},{"id":"https://openalex.org/C3019981671","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Immediate release","level":2,"score":0.266400009393692},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.26269999146461487},{"id":"https://openalex.org/C2779484521","wikidata":"https://www.wikidata.org/wiki/Q5975478","display_name":"IVIVC","level":5,"score":0.2583000063896179},{"id":"https://openalex.org/C163588942","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Controlled release","level":2,"score":0.2572999894618988},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.2551000118255615}],"mesh":[{"descriptor_ui":"D000282","descriptor_name":"Administration, Intravaginal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011374","descriptor_name":"Progesterone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011374","descriptor_name":"Progesterone","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014621","descriptor_name":"Vagina","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014622","descriptor_name":"Vaginal Creams, Foams, and Jellies","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D065546","descriptor_name":"Drug Liberation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066228","descriptor_name":"Vaginal Absorption","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.xphs.2025.104046","doi":"https://doi.org/10.1016/j.xphs.2025.104046","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.xphs.2025.104046","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:41173270","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41173270","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical sciences","raw_type":"Journal Article"},{"id":"pmh:oai:ruj.uj.edu.pl:item/565099","doi":null,"is_oa":true,"landing_page_url":"https://ruj.uj.edu.pl/handle/item/565099","pdf_url":null,"source":{"id":"https://openalex.org/S4306401249","display_name":"Jagiellonian University Repository (Jagiellonian University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126596746","host_organization_name":"Jagiellonian University","host_organization_lineage":["https://openalex.org/I126596746"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:ruj.uj.edu.pl:item/565099","doi":null,"is_oa":true,"landing_page_url":"https://ruj.uj.edu.pl/handle/item/565099","pdf_url":null,"source":{"id":"https://openalex.org/S4306401249","display_name":"Jagiellonian University Repository (Jagiellonian University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126596746","host_organization_name":"Jagiellonian University","host_organization_lineage":["https://openalex.org/I126596746"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W81939387","https://openalex.org/W195581554","https://openalex.org/W201789006","https://openalex.org/W1679568553","https://openalex.org/W1771238497","https://openalex.org/W1793056014","https://openalex.org/W1941905443","https://openalex.org/W1966749001","https://openalex.org/W1978554346","https://openalex.org/W1995634417","https://openalex.org/W1998074968","https://openalex.org/W2004306984","https://openalex.org/W2028165836","https://openalex.org/W2067309612","https://openalex.org/W2070057118","https://openalex.org/W2078510487","https://openalex.org/W2094105274","https://openalex.org/W2113830209","https://openalex.org/W2138840482","https://openalex.org/W2168399535","https://openalex.org/W2170572556","https://openalex.org/W2341647963","https://openalex.org/W2516964306","https://openalex.org/W2547117895","https://openalex.org/W2590487824","https://openalex.org/W2608778020","https://openalex.org/W2757142523","https://openalex.org/W2894356471","https://openalex.org/W2908654951","https://openalex.org/W2962701002","https://openalex.org/W2980442260","https://openalex.org/W2981180224","https://openalex.org/W2999973294","https://openalex.org/W3001733618","https://openalex.org/W3027131822","https://openalex.org/W3043800258","https://openalex.org/W3128371112","https://openalex.org/W3178414713","https://openalex.org/W4220781801","https://openalex.org/W4280574658","https://openalex.org/W4285493710","https://openalex.org/W4292085095","https://openalex.org/W4294915367","https://openalex.org/W4311053656","https://openalex.org/W4318930130","https://openalex.org/W4385269679","https://openalex.org/W4392552991","https://openalex.org/W4394894221"],"related_works":["https://openalex.org/W3001733618","https://openalex.org/W4392552991","https://openalex.org/W2914645825","https://openalex.org/W2993827462","https://openalex.org/W4396688588","https://openalex.org/W6906690261","https://openalex.org/W4362508784","https://openalex.org/W2990882447","https://openalex.org/W4402127184","https://openalex.org/W4353032322"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2025-10-30T00:00:00"}